Showing 7,441 - 7,460 results of 20,793 for search '"Therapy"', query time: 0.10s Refine Results
  1. 7441

    Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump by A.B.R. Thomson

    Published 1989-01-01
    “…More patients are free from symptoms earlier on omeprazole therapy than with the H2 receptor antagonists. Omeprazole is also effective in healing and symptom relief even where prolonged H2 receptor antagonist therapy has been unsuccessful. …”
    Get full text
    Article
  2. 7442
  3. 7443

    Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management by Anna J. Lomax, Jennifer Lim, Robert Cheng, Arianne Sweeting, Patricia Lowe, Neil McGill, Nicholas Shackel, Elizabeth L. Chua, Catriona McNeil

    Published 2018-01-01
    “…We retrospectively evaluated the incidence, kinetics, and management of irAE in 41 patients receiving anti-PD-1 antibody therapy (pembrolizumab) for advanced melanoma. 63% received prior anti-CTLA-4 antibody therapy (ipilimumab). …”
    Get full text
    Article
  4. 7444

    Early Driving Pressure Changes Predict Outcomes during Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome by Harry Magunia, Helene A. Haeberle, Philipp Henn, Martin Mehrländer, Peer O. Vlatten, Valbona Mirakaj, Peter Rosenberger, Michael Koeppen

    Published 2020-01-01
    “…Extracorporeal membrane oxygenation (ECMO) serves as a rescue therapy when systemic hypoxia persists despite conventional care for severe acute respiratory distress syndrome (ARDS). …”
    Get full text
    Article
  5. 7445

    Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report by Chang Jiang, Shanxian Guo

    Published 2025-02-01
    “…Besides, when tumor progression and IRH recurrence occur simultaneously, providing effective immunosuppressive therapy and reasonably arranging systemic anti-tumor therapy may bring clinical benefits to patients.…”
    Get full text
    Article
  6. 7446

    Trimethoprim/sulfamethoxazole-induced acute renal failure: A case report by Gabriella Nucera, Valentina Raffaelli, Lisa Caliari, Giulia Cantoni, Pietro Marino

    Published 2017-07-01
    “…Subsequently, we started a new antibiotic therapy with trimethoprim/sulfamethoxazole (TMP/SMX) adjusted to renal functioning. …”
    Get full text
    Article
  7. 7447
  8. 7448

    Evaluation of the longitudinal deformation of left ventricle and its changes in myocardial infarction and coronary heart disease with obstructive coronary artery lesions by N.V. Tytarenko, M.P. Kopytsya, I.V. Rodionova, A.V. Kobets

    Published 2021-07-01
    “…In patients with myocardial infarction without ST-segment elevation, GLS measurement may assist in the selection of patients who need urgent reperfusion therapy. In coronary heart disease, GLS can complement the conventional assessment of wall movement; replace the need for additional non-invasive testing for some patients with suboptimal stress tests. …”
    Get full text
    Article
  9. 7449

    The Persian Version of the "Participation Measure-3 Domains, 4 Dimensions": Translation, Cultural Adaptation, Face and Content Validity by Diba Sharifi, Laleh Lajevardi, Ghorban Taghizadeh, Akram Azad

    Published 2025-03-01
    “…Background and Objectives: Investigating the impact of occupational therapy interventions on the participation levels of adults with stroke is crucial due to its significant influence on their satisfaction and quality of life (QOL). …”
    Get full text
    Article
  10. 7450

    Management of patients with dry eye syndrome with systemic autoimmune and infectious diseases by G.M. Chernakova, E.A. Kleshcheva

    Published 2018-07-01
    “…The common pathogenetic processes of development of DES in patients with systemic infectious and non-infectious diseases allows to consider the reduction of oxidative stress as the main direction of the drug therapy. Undoubtedly, systemic therapy of the underlying disease is mandatory, however,&nbsp;<br> it is the ophthalmologist’s responsibility to identify symptoms of tear production decrease against the background of these diseases, to establish the severity of DES and to prescribe therapy that improves the quality of life of patients.…”
    Get full text
    Article
  11. 7451
  12. 7452

    The Antinociceptive Effect of Light-Emitting Diode Irradiation on Incised Wounds Is Correlated with Changes in Cyclooxygenase 2 Activity, Prostaglandin E2, and Proinflammatory Cyto... by Yuan-Yi Chia, Chien-Cheng Liu, Guan-Ming Feng, Chia-Chih Alex Tseng, Kuo-Chuan Hung, Chih-Chieh Chen, Ping-Heng Tan

    Published 2017-01-01
    “…Behavioral tests and analysis of skin tissue were performed after LED therapy. Results. LED therapy attenuated the decrease in thermal withdrawal latency in all the irradiated groups and the decrease in the mechanical withdrawal threshold in the L-I group only. …”
    Get full text
    Article
  13. 7453

    Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database by Ariel Berger, John Edelsberg, Simon Teal, Marko A. Mychaskiw, Gerry Oster

    Published 2014-02-01
    “…Post-index use of sildenafil was then examined in terms of the numbers of pharmacy claims and therapy-days, the medication possession ratio (MPR), and the incidence of therapy switching. …”
    Get full text
    Article
  14. 7454
  15. 7455
  16. 7456

    Impact of Treatment on Rate of Biphasic Reaction in Children with Anaphylaxis by William Bonadio, Connor Welsh, Brad Pradarelli, Yunfai Ng

    Published 2024-10-01
    “…All BPR episodes occurred within the 0–4 hour interval after initiating therapy, whereas no patient manifested a BPR requiring an additional dose of IM EPI during the 4–48 hours after initiating therapy (P = <0.001, 95% CI 0–1.3%). …”
    Get full text
    Article
  17. 7457
  18. 7458
  19. 7459
  20. 7460

    A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment? by Isabelle Mohr, Patrick Lamade, Christophe Weber, Viola Leidner, Sebastian Köhrer, Alexander Olkus, Matthias Lang, Andrea Langel, Patrischia Dankert, Melanie Greibich, Silke Wolf, Holger Zimmer, Patrick Michl, Aurélia Poujois, Karl Heinz Weiss, Uta Merle

    Published 2025-01-01
    “…Methods Eighty-four patients with a confirmed diagnosis of WD treated with chelators (50% of patients with D-Penicillamine and 50% with trientine) and with pairwise 24-h-UCE values on-therapy and off-therapy were included in the analysis. …”
    Get full text
    Article